Therus Corporation is developing the Therus® Acoustic Hemostasis System, a medical device designed for rapid, durable, noninvasive sealing of femoral artery access punctures following catheterization-laboratory procedures such as angiography and angioplasty.
- Singular product focus on noninvasive femoral artery access closure, a large, under-penetrated and growing market opportunity
- Therus System addresses the limitations of manual compression and existing vascular access closure devices
- Device utilizes focused ultrasound transmitted through skin to thermally coagulate native collagen to positively seal the access site - no foreign materials are implanted
- Product feasibility proven in three human clinical trials involving 162 patients
- Experienced management team and advisory board
- Strong intellectual property portfolio
- Product launch planned for 2008
|
